2021-RD-Soumya-Kannan

Conference Video|Duration: 28:01
November 18, 2021
Please login to view this video.
  • Video details
     
     
    Programmable genome editing technologies have an unparalleled potential to treat human diseases. However, challenges remain in effectively delivering genome editing reagents to cells in vivo, which is required to fully realize this potential. Here, we discuss our efforts to miniaturize genome editing systems through exploration of biological diversity, leading to the discovery of novel reprogrammable systems that are more compatible with current therapeutic delivery technologies.
Locked Interactive transcript
Please login to view this video.
  • Video details
     
     
    Programmable genome editing technologies have an unparalleled potential to treat human diseases. However, challenges remain in effectively delivering genome editing reagents to cells in vivo, which is required to fully realize this potential. Here, we discuss our efforts to miniaturize genome editing systems through exploration of biological diversity, leading to the discovery of novel reprogrammable systems that are more compatible with current therapeutic delivery technologies.
Locked Interactive transcript